This from HGL's FY20... (my emphasis)
"...BLC Cosmetics imports and distributes high quality skincare products and devices to beauty salons, spas,
wellness centres and skincare clinics in the Australia Pacific region. BLC is a wholly owned subsidiary of HGL.
Notwithstanding closure of customer premises through COVID-19, BLC increased revenues by over 16% in the
year to $6.0 million. Thalgo continues to be the main brand for the business and has performed in line with
expectations. The company secured the rights to distribute the HydroPeptide cosmeceutical brand which was
relaunched by BLC in March. Growth will be challenged with the withdrawal of the agency for Alpha-H brand
during the first half of FY21. BLC continues to explore new distribution and brand opportunities to complement its
existing house of brands growth strategy.
Despite a small reduction in gross margins, due to a combination of foreign exchange and promotional activity,
FY20 saw BLC return to profitability during the year with a positive EBIT of $0.1 million improved from a $0.6
million loss in FY19, assisted by JobKeeper payments and leadership on this business unit
and this from HGL's HY21...
I'm no business valuation expert but, with a Net Asset Value of $100k (6 mths ago) and EBIT of $100k (incl artificial financial assistance) after a previous loss of $600k - I can see why a sale price with EBITDA multiple of 6 was accepted by HGL.
For CDY - I really hope spending $1 million and issuing another >32 million shares in order to "double revenue" turns out to be a master stroke by our leadership. Given the history on the way they have managed the "expenditure", I will be very interested to see whether they finally turn a taxable net profit - or will it just double the losses?Standard Disclaimer:
THIS POST REPRESENTS MY PERSONAL OPINION, PURSUANT TO SECTION 14 OF THE NZ BILL OF RIGHTS ACT 1990 AND SECTION 19, ARTICLE 4(1) OF THE AUSTRALIAN BILL OF RIGHTS ACT 2017. MY OPINION IS NOT INTENDED TO BE INVESTMENT ADVICE. I AM NOT A REGISTERED INVESTMENT ADVISER. I RECOMMEND CONSULTING A LICENSED INVESTMENT ADVISER PRIOR TO SPENDING YOUR CAPITAL. THIS POST MAY, OR MAY NOT REPRESENT THE TRUE STATE OF THIS COMPANY’S AFFAIRS BUT IN ANY EVENT, IT SHOULD BE TREATED AS COINCIDENTAL IN EVERY INSTANCE. ANY RELIANCE OR ACTION BASED ON ANY PART OF THIS POST, IS DONE SO AT YOUR OWN RISK. HAPPY INVESTING!
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid to Acquire BLC Cosmetics Pty Ltd
Ann: Cellmid to Acquire BLC Cosmetics Pty Ltd, page-12
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online